Feedback / Questions
eblasakimab (ASLAN004) - ASLAN Pharma, Zenyaku Holdings
https://www.globenewswire.com/news-release/2023/11/03/2773084/0/en/ASLAN-Pharmaceuticals-Presents-New-Data-on-Eblasakimab-in-Atopic-Dermatitis-and-COPD-Translational-Models-at-the-7th-Dermatology-Drug-Development-Summit.html
Nov 3, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next